209 related articles for article (PubMed ID: 32893672)
21. Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists.
Xu F; Zhao Y; Zhou H; Li C; Zhang X; Hou T; Qu L; Wei L; Wang J; Liu Y; Liang X
Bioorg Med Chem Lett; 2020 Dec; 30(24):127650. PubMed ID: 33127539
[TBL] [Abstract][Full Text] [Related]
22. [A New Pain Regulatory System via the Brain Long Chain Fatty Acid Receptor GPR40/FFA1 Signal].
Nakamoto K
Yakugaku Zasshi; 2017; 137(2):199-204. PubMed ID: 28154332
[TBL] [Abstract][Full Text] [Related]
23. Activation of GPR40 Suppresses AGE-Induced Reduction of Type II Collagen and Aggrecan in Human SW1353 Chondrocytes.
Gu J; Lin H; Zhang Y; Xu T; Wang T; Xue X; Zhang W; Liu H
Drug Des Devel Ther; 2020; 14():2371-2379. PubMed ID: 32606604
[TBL] [Abstract][Full Text] [Related]
24. Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.
Milligan G; Alvarez-Curto E; Watterson KR; Ulven T; Hudson BD
Br J Pharmacol; 2015 Jul; 172(13):3254-65. PubMed ID: 25131623
[TBL] [Abstract][Full Text] [Related]
25. Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain.
Nakamoto K; Nishinaka T; Sato N; Mankura M; Koyama Y; Kasuya F; Tokuyama S
PLoS One; 2013; 8(12):e81563. PubMed ID: 24349089
[TBL] [Abstract][Full Text] [Related]
26. Omega-3 polyunsaturated fatty acids protect human hepatoma cells from developing steatosis through FFA4 (GPR120).
Kang S; Huang J; Lee BK; Jung YS; Im E; Koh JM; Im DS
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):105-116. PubMed ID: 29126901
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic signaling of the free-fatty acid receptors FFA1 and FFA4 in human breast carcinoma cells.
Karmokar PF; Moniri NH
Biochem Pharmacol; 2022 Dec; 206():115328. PubMed ID: 36309079
[TBL] [Abstract][Full Text] [Related]
28. Free fatty acid receptor (FFAR) agonists inhibit proliferation of human ovarian cancer cells.
Hopkins MM; Meier KE
Prostaglandins Leukot Essent Fatty Acids; 2017 Jul; 122():24-29. PubMed ID: 28735625
[TBL] [Abstract][Full Text] [Related]
29. The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines.
Senatorov IS; Moniri NH
Biochem Pharmacol; 2018 Apr; 150():170-180. PubMed ID: 29452095
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological Tool Compounds for the Free Fatty Acid Receptor 4 (FFA4/GPR120).
Hansen SV; Ulven T
Handb Exp Pharmacol; 2017; 236():33-56. PubMed ID: 27807695
[TBL] [Abstract][Full Text] [Related]
31. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
Argilés JM; Figueras M; Ametller E; Fuster G; Olivan M; de Oliveira CC; López-Soriano FJ; Isfort RJ; Busquets S
Muscle Nerve; 2008 Feb; 37(2):190-5. PubMed ID: 17912749
[TBL] [Abstract][Full Text] [Related]
32. GPR119, a Major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Coacting in Synergy With FFA1 (GPR40).
Ekberg JH; Hauge M; Kristensen LV; Madsen AN; Engelstoft MS; Husted AS; Sichlau R; Egerod KL; Timshel P; Kowalski TJ; Gribble FM; Reiman F; Hansen HS; Howard AD; Holst B; Schwartz TW
Endocrinology; 2016 Dec; 157(12):4561-4569. PubMed ID: 27779915
[TBL] [Abstract][Full Text] [Related]
33. Long Chain Fatty Acids as Modulators of Immune Cells Function: Contribution of FFA1 and FFA4 Receptors.
Hidalgo MA; Carretta MD; Burgos RA
Front Physiol; 2021; 12():668330. PubMed ID: 34276398
[TBL] [Abstract][Full Text] [Related]
34. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
[TBL] [Abstract][Full Text] [Related]
35. Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia.
Tseng YC; Kulp SK; Lai IL; Hsu EC; He WA; Frankhouser DE; Yan PS; Mo X; Bloomston M; Lesinski GB; Marcucci G; Guttridge DC; Bekaii-Saab T; Chen CS
J Natl Cancer Inst; 2015 Dec; 107(12):djv274. PubMed ID: 26464423
[TBL] [Abstract][Full Text] [Related]
36. Non-Acidic Free Fatty Acid Receptor 4 Agonists with Antidiabetic Activity.
Azevedo CM; Watterson KR; Wargent ET; Hansen SV; Hudson BD; Kępczyńska MA; Dunlop J; Shimpukade B; Christiansen E; Milligan G; Stocker CJ; Ulven T
J Med Chem; 2016 Oct; 59(19):8868-8878. PubMed ID: 27570890
[TBL] [Abstract][Full Text] [Related]
37. Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor.
Lin DC; Guo Q; Luo J; Zhang J; Nguyen K; Chen M; Tran T; Dransfield PJ; Brown SP; Houze J; Vimolratana M; Jiao XY; Wang Y; Birdsall NJ; Swaminath G
Mol Pharmacol; 2012 Nov; 82(5):843-59. PubMed ID: 22859723
[TBL] [Abstract][Full Text] [Related]
38. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
39. EXT418, a novel long-acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice.
Kerr HL; Krumm K; Lee II; Anderson B; Christiani A; Strait L; Breckheimer BA; Irwin B; Jiang AS; Rybachok A; Chen A; Caeiro L; Dacek E; Hall DB; Kostyla CH; Hales LM; Soliman TM; Garcia JM
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1337-1348. PubMed ID: 36942661
[TBL] [Abstract][Full Text] [Related]
40. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.
Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):919-933. PubMed ID: 38572511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]